Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No. II)
The causation theory is supported by FDA safety communications and scientific studies indicating that Varenicline can stimulate nicotinic acetylcholine receptors, potentially leading to neuropsychiatric disturbances such as depression and suicidal ideation, as well as increasing cardiovascular risks like myocardial infarction and stroke. These adverse effects are especially pronounced in individuals with pre-existing health conditions, and the evidence suggests a plausible causal link supported by meta-analyses and expert testimonies.
17
Pending actions
17
Total actions filed
Active
Status
12/22/2022
Established
Filing deadline
Claims can be filed until late 2025, with specific deadlines set in case management orders; exact final deadlines require review of the latest court orders.
Who qualifies
Plaintiffs must have used Chantix for a minimum period, typically at least 12 weeks, with documented exposure to the drug. They must have experienced injuries such as neuropsychiatric symptoms or cardiovascular events, confirmed through medical diagnoses. Exclusion criteria generally include pre-existing conditions that could independently cause such injuries, although specific thresholds for dosage or duration are not explicitly detailed in publicly available court documents.
Products involved
- Chantix (Varenicline)
Alleged injuries
- psychiatric effects (depression, suicidal ideation, psychosis)
- cardiovascular events (heart attack, stroke)
Bellwether trials
The first bellwether trial is scheduled for late 2026, with subsequent trials through 2027. No final verdicts have been reported yet.
Settlement landscape
No publicly available specific settlement estimates or average case values have been disclosed. Legal reports suggest ongoing negotiations, but no concrete figures are publicly reported at this time.
Lead counsel
- Scott+Scott
- Motley Rice
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
